Male Breast Carcinoma Active Not Recruiting Phase 2 Trials for Temsirolimus (DB06287)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00376688Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast CancerTreatment